메뉴 건너뛰기




Volumn 9, Issue 11, 1998, Pages 1213-1217

Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma

Author keywords

Chemotherapy; CHOP; Etoposide; High grade non Hodgkin's lymphoma; Risk factors

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VINCRISTINE;

EID: 7844226294     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008446430765     Document Type: Article
Times cited : (12)

References (30)
  • 1
    • 0017132731 scopus 로고
    • Hydroxyldaunomycin (adriamycin) combination chemotheraphy in malignant lymphoma
    • McKelvey EM, Gottlieb JA, Wilson HF. et al. Hydroxyldaunomycin (adriamycin) combination chemotheraphy in malignant lymphoma. Cancer 1476; 38: 1484-93.
    • (1476) Cancer , vol.38 , pp. 1484-1493
    • McKelvey, E.M.1    Gottlieb, J.A.2    Wilson, H.F.3
  • 2
    • 0025105137 scopus 로고
    • The m-BACOD combination chemotherapy regimen in large-cell lymphoma: Analysis of the completed trial and comparison with the m-BACOD regimen
    • Shipp MA, Young B, Harrington DP et al. The m-BACOD combination chemotherapy regimen in large-cell lymphoma: Analysis of the completed trial and comparison with the m-BACOD regimen. J Clin Oncol 1990; 8: 84-93.
    • (1990) J Clin Oncol , vol.8 , pp. 84-93
    • Shipp, M.A.1    Young, B.2    Harrington, D.P.3
  • 3
    • 0023840154 scopus 로고
    • COPBLAM III infusional combination chemotherapy for diffuse large-cell lymphoma
    • Boyd DB, Coleman M, Papish SW et al. COPBLAM III infusional combination chemotherapy for diffuse large-cell lymphoma. J Clin Oncol 1988; 6: 425-33.
    • (1988) J Clin Oncol , vol.6 , pp. 425-433
    • Boyd, D.B.1    Coleman, M.2    Papish, S.W.3
  • 4
    • 0025958183 scopus 로고
    • Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: Results of a prospective randomized trial
    • Longo D, DeVita VT, Duffey P et al. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: Results of a prospective randomized trial. J Clin Oncol 1991; 9: 25-38.
    • (1991) J Clin Oncol , vol.9 , pp. 25-38
    • Longo, D.1    DeVita, V.T.2    Duffey, P.3
  • 5
    • 0023987023 scopus 로고
    • MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations
    • Connors SM, Klimo P. MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations. Semin Hematol 1988; 25: 41-6.
    • (1988) Semin Hematol , vol.25 , pp. 41-46
    • Connors, S.M.1    Klimo, P.2
  • 6
    • 0025790543 scopus 로고
    • Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma
    • Sweetenham JW, Mead GM, Whitehouse JMA. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma. J Clin Oncol 1991; 9: 2202-9.
    • (1991) J Clin Oncol , vol.9 , pp. 2202-2209
    • Sweetenham, J.W.1    Mead, G.M.2    Whitehouse, J.M.A.3
  • 7
    • 0027394689 scopus 로고
    • Comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate or high-grade non-Hodgkin's lymphomas
    • Fisher RI, Gayner ER, Dahlberg M et al. Comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate or high-grade non-Hodgkin's lymphomas. N Engl J Med 1993; 328: 1002-6.
    • (1993) N Engl J Med , vol.328 , pp. 1002-1006
    • Fisher, R.I.1    Gayner, E.R.2    Dahlberg, M.3
  • 8
    • 0027468191 scopus 로고
    • A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: A prospective randomized study
    • Takagi T, Sampi K, Sawada U et al. A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: A prospective randomized study, Int J Hematol 1993; 57: 67-71.
    • (1993) Int J Hematol , vol.57 , pp. 67-71
    • Takagi, T.1    Sampi, K.2    Sawada, U.3
  • 9
    • 0028293076 scopus 로고
    • Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma
    • Cooper IA. Wolf MM, Fox RM et al for the New Zealand Lymphoma Group. Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 769-78.
    • (1994) J Clin Oncol , vol.12 , pp. 769-778
    • Cooper, I.A.1    Wolf, M.M.2    Fox, R.M.3
  • 10
    • 9344248372 scopus 로고    scopus 로고
    • A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: A British National Lymphoma Investigation report
    • Linch DC, Vaughan Hudson B, Hancock BW et al. A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: A British National Lymphoma Investigation report. Br J Cancer 1996; 74: 318-22.
    • (1996) Br J Cancer , vol.74 , pp. 318-322
    • Linch, D.C.1    Vaughan Hudson, B.2    Hancock, B.W.3
  • 11
    • 0025836032 scopus 로고
    • Lymphoma in the elderly
    • Fiorentino MV. Lymphoma in the elderly. Leukemia 1991; 5: 79 -85.
    • (1991) Leukemia , vol.5 , pp. 79-85
    • Fiorentino, M.V.1
  • 12
    • 0021887662 scopus 로고
    • VP-16-213 in the treatment of stage III and IV diffuse large-cell lymphoma
    • Jacobs P, King HS, Dent DM, Hayes M, VP-16-213 in the treatment of stage III and IV diffuse large-cell lymphoma. Cancer 1985; 56: 1006-13.
    • (1985) Cancer , vol.56 , pp. 1006-1013
    • Jacobs, P.1    King, H.S.2    Dent, D.M.3    Hayes, M.4
  • 13
    • 0027520881 scopus 로고
    • Chronic administration of etoposide in the treatment of non-Hodgkin's lymphoma
    • Hainsworth JD, Chronic administration of etoposide in the treatment of non-Hodgkin's lymphoma. Leuk Lymph 1993; 10 (Suppl): 65-72.
    • (1993) Leuk Lymph , vol.10 , Issue.SUPPL. , pp. 65-72
    • Hainsworth, J.D.1
  • 14
    • 0019254230 scopus 로고
    • VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine and prednisone in the treatment of non-Hodgkin's lymphomas
    • Hansen MM, Blomfield CD, Jörgensen J et al. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine and prednisone in the treatment of non-Hodgkin's lymphomas. Cancer Treat Rep 1980; 64: 1135-7.
    • (1980) Cancer Treat Rep , vol.64 , pp. 1135-1137
    • Hansen, M.M.1    Blomfield, C.D.2    Jörgensen, J.3
  • 15
    • 0027182362 scopus 로고
    • EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma
    • Wilson WH, Bryant G, Bates et al. EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1573-82.
    • (1993) J Clin Oncol , vol.11 , pp. 1573-1582
    • Wilson, W.H.1    Bryant, G.2    Bates3
  • 16
    • 0028005329 scopus 로고
    • Randomised comparison of CHOEP versus alternating hCHOP. IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial
    • Koppler H, Pfluger KH, Eschenbach I et al. Randomised comparison of CHOEP versus alternating hCHOP. IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial. Ann Oncol 1994: 5: 49-55.
    • (1994) Ann Oncol , vol.5 , pp. 49-55
    • Koppler, H.1    Pfluger, K.H.2    Eschenbach, I.3
  • 17
    • 0028938612 scopus 로고
    • Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma
    • Carrion JR, Garcia Arroyo FR, Salinas P, Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma. Am J Clin Oncol 1995; 18: 44-6.
    • (1995) Am J Clin Oncol , vol.18 , pp. 44-46
    • Carrion, J.R.1    Garcia Arroyo, F.R.2    Salinas, P.3
  • 18
    • 0029587694 scopus 로고
    • Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma-a multicenter phase II study
    • Bergmann L, Karakas T, Lautenschläger G et al. Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma-a multicenter phase II study. Ann Oncol 1995; 6: 1019-24.
    • (1995) Ann Oncol , vol.6 , pp. 1019-1024
    • Bergmann, L.1    Karakas, T.2    Lautenschläger, G.3
  • 20
    • 0023930572 scopus 로고
    • Updated Kiel Classification for lymphoma
    • Stansfeld A, Diebold J, Kapanci Y et al. Updated Kiel Classification for lymphoma. Lancet 1988; i: 292-3.
    • (1988) Lancet , vol.1 , pp. 292-293
    • Stansfeld, A.1    Diebold, J.2    Kapanci, Y.3
  • 21
    • 0015150080 scopus 로고
    • Report of the committee on Hodgkin's disease staging classification
    • Carbone PP, Kaplan HS, Musshoff K et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1.
    • (1971) Cancer Res , vol.31 , pp. 1860-1861
    • Carbone, P.P.1    Kaplan, H.S.2    Musshoff, K.3
  • 22
    • 0023143097 scopus 로고
    • Results of MIME salvage regimen for recurrent or refractory lymphoma
    • Cabanillas F, Hagemeister FB, McLaughlin P et al. Results of MIME salvage regimen for recurrent or refractory lymphoma. J Clin Oncol 1987; 5: 407-12.
    • (1987) J Clin Oncol , vol.5 , pp. 407-412
    • Cabanillas, F.1    Hagemeister, F.B.2    McLaughlin, P.3
  • 23
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EM, Meier P. Nonparametric estimation from incomplete observations, J Am Stat Assoc 1958; 53: 457-81.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.M.1    Meier, P.2
  • 24
    • 7844242228 scopus 로고
    • Design and analysis of randomised clinical trials requiring prolonged observations of each patient
    • Peto R, Pike MC, Armilage P et al. Design and analysis of randomised clinical trials requiring prolonged observations of each patient. Br J Cancer 1971; 38: 1484-93.
    • (1971) Br J Cancer , vol.38 , pp. 1484-1493
    • Peto, R.1    Pike, M.C.2    Armilage, P.3
  • 25
    • 0028012062 scopus 로고
    • Prognostic factors in aggressive non-Hodgkin's lymphoma who has high-risk disease
    • Shipp MA, Prognostic factors in aggressive non-Hodgkin's lymphoma who has high-risk disease. Blood 1994; 83: 1165-73.
    • (1994) Blood , vol.83 , pp. 1165-1173
    • Shipp, M.A.1
  • 26
    • 0025970652 scopus 로고
    • The evolving role of etoposide in the management of lymphomas and Hodgkin's disease
    • O'Reilly SE, Klimo P, Connors JM. The evolving role of etoposide in the management of lymphomas and Hodgkin's disease. Cancer 1991; 67: 271-80.
    • (1991) Cancer , vol.67 , pp. 271-280
    • O'Reilly, S.E.1    Klimo, P.2    Connors, J.M.3
  • 27
    • 0022504479 scopus 로고
    • Investigation of the addition potential of tenoposide and vincristine in non-Hodgkin lymphomas
    • Australian and New Zealand lymphoma group. Investigation of the addition potential of tenoposide and vincristine in non-Hodgkin lymphomas, Cancer Treat Rep 1986: 70: 985-90.
    • (1986) Cancer Treat Rep , vol.70 , pp. 985-990
  • 28
    • 0030964191 scopus 로고    scopus 로고
    • Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma
    • Zinzani PL, Pavone E, Storti S et al. Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma. Blood 1997; 89: 3974-9.
    • (1997) Blood , vol.89 , pp. 3974-3979
    • Zinzani, P.L.1    Pavone, E.2    Storti, S.3
  • 29
    • 0026667676 scopus 로고
    • Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: A randomized controlled trial
    • Pettengell R, Gurney H, Radford JA et al. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: A randomized controlled trial. Blood 1992; 80: 1430-6.
    • (1992) Blood , vol.80 , pp. 1430-1436
    • Pettengell, R.1    Gurney, H.2    Radford, J.A.3
  • 30
    • 0027517297 scopus 로고
    • Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyle-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas
    • Gerhartz HH, Engelhard M, Meusers P et al. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyle-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood 1993; 82: 2329-39.
    • (1993) Blood , vol.82 , pp. 2329-2339
    • Gerhartz, H.H.1    Engelhard, M.2    Meusers, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.